Skip to main content

Want a detailed portfolio tracker?

Opko Health (OPK) Total Assets (2008 - 2026)

Opko Health (OPK) total assets from Dec 31, 2008 to Mar 31, 2026. The current Opko Health (OPK) total assets is $1.86B. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Assets

Total Assets

Opko Health (OPK) Total Assets CAGR table

PeriodCAGR
1 Year TTM-9.43%
3 Years TTM-4.59%
5 Years TTM-4.35%
10 Years TTM-2.64%

Annual Total Assets change of Opko Health (OPK)

YearTotal AssetsChange
2025$1.93B
-12.19%
2024$2.20B
+9.37%
2023$2.01B
-7.18%
2022$2.17B
-9.69%
2021$2.40B
-2.97%
2020$2.47B
+7.09%
2019$2.31B
-5.79%
2018$2.45B
-5.36%
2017$2.59B
-6.39%
2016$2.77B
-1.16%
2015$2.80B
N/A
2015$0
-100.00%
2014$1.27B
-8.90%
2013$1.39B
+380.12%
2012$290M
+26.29%
2011$229M
+194.78%
2010$78M
N/A
2009$0
N/A
2008$0
N/A

Comparison Opko Health (OPK) total assets with competitors

Opko Health (OPK) total assets is $1.86B.

TickerNameTotal AssetsUpside
TMOThermo Fisher Scientific Inc$113.28B+6000.87%
DHRDanaher Corp$83.54B+4399.35%
IQVIQVIA Holdings Inc$29.68B+1498.18%
WATWaters Corp$24.53B+1221.14%
LHLaboratory Corp Of America Holdings$19.09B+927.96%
DGXQuest Diagnostics Inc$16.67B+797.94%
ICLRIcon Plc$16.27B+776.23%
AAgilent Technologies Inc$12.81B+590.06%
RVTYRevvity Inc$12.00B+546.09%
CRLCharles River Laboratories International Inc$7.73B+316.32%
ILMNIllumina Inc$6.56B+253.24%
QGENQiagen NV$6.28B+238.28%
EXASExact Sciences Corp$5.86B+215.63%
RDNTRadnet Inc$3.89B+109.25%
MTDMettler-Toledo International Inc$3.67B+97.59%
IDXXIdexx Laboratories Inc$3.39B+82.33%
SHCSotera Health Company$3.24B+74.27%
GRALGRAIL Inc$2.80B+50.98%
NTRANatera Inc$2.61B+40.80%
MEDPMedpace Holdings Inc$2.13B+14.69%
GHGuardant Health Inc$1.92B+3.15%
VCYTVeracyte Inc$1.44B-22.64%
NEONeogenomics Inc$1.36B-26.76%
FLGTFulgent Genetics Inc$1.16B-37.72%
BNRBurning Rock Biotech Ltd$885.30M-52.32%
NOTVInotiv Inc$702.42M-62.17%
BLLNBilliontoone Inc - Class A$700.73M-62.26%
TWSTTwist Bioscience Corp$676.21M-63.58%
MYGNMyriad Genetics Inc$673.70M-63.72%
CSTLCastle Biosciences Inc$547.80M-70.50%
WGSGeneDx Holdings Corp - Class A$506.30M-72.73%
ADPTAdaptive Biotechnologies Corp$505.94M-72.75%
CDNACaredx Inc$411.06M-77.86%
PSNLPersonalis Inc$325.39M-82.48%
FONRFonar Corp$219.22M-88.19%
PREPrenetics Global Ltd - Class A$203.52M-89.04%
MDXHMDxHealth SA$147.95M-92.03%
BDSXBiodesix Inc$94.64M-94.90%
PRPHProPhase Labs Inc$65.70M-96.46%
XGNExagen Inc$51.96M-97.20%
IMDXInsight Molecular Diagnostics Inc$40.43M-97.82%
XWELXWELL Inc$24.99M-98.65%
PRPOPrecipio Inc$20.80M-98.88%
ADVBAdvanced Biomed Inc$10.65M-99.43%
APDNApplied Dna Sciences Inc$9.93M-99.46%
ISPCiSpecimen Inc$9.53M-99.49%
BIAFBioAffinity Technologies Inc$7.95M-99.57%
MYNZMainz Biomed N.V.$7.72M-99.58%
MBAICheckCap Ltd$7.49M-99.60%
NDRAENDRA Life Sciences Inc$3.44M-99.81%
CHEKCheck-Cap Ltd$377000.00-99.98%